PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 4 days 11 minutes
Ensuring Long-Term Success in Advanced Ovarian Cancer: Sequencing Therapy Based on Science
Ensuring Long-Term Success in Advanced Ovarian Cancer: Sequencing Therapy Based on Science
Optimising Outcomes With PARPs in Advanced Ovarian Cancer
Optimising Outcomes With PARPs in Advanced Ovarian Cancer
Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies
Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses
Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them
Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them
The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care
The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care
The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal
The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal
Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action
Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action
Improving Outcomes in Non-Metastatic CRPC: Case by Case
Improving Outcomes in Non-Metastatic CRPC: Case by Case
An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?
An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?